In Partnership with:

Richmond Times-Dispatch

Cancer

28601 Stories, most recent news story added 23 minutes ago

Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute

Marketwire - 1 hour 46 minutes ago

HALIFAX, NOVA SCOTIA--(Marketwire - Nov. 10, 2009) - Immunovaccine Inc. (TSX VENTURE:IMV) , a vaccine development company, has signed a collaborative agreement with the National Cancer Institute (NCI) in Maryland, USA. The research collaboration involves formulating NCI's cancer vaccine antigens in DepoVaxT, Immunovaccine's vaccine enhancement system. "NCI is a world leader in the study of ...